Data Sources—National Institutes for Health (NIH)
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Surveillance, Epidemiology, and End Results Program (SEER)
U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch.
The SEER Program of the National Cancer Institute is the most authoritative source of information on cancer incidence and survival in the United States.
The SEER Program currently collects and publishes cancer incidence and survival data from 12 population-based cancer registries and 3 supplemental registries covering approximately 14 percent of the U.S. population. Geographic areas were selected for inclusion in the SEER Program based on their ability to operate and maintain a high-quality population-based cancer reporting system and for their epidemiologically significant population subgroups.
SEER Population Data
The county population estimates implemented in the NCI SEER*Stat software for the calculation of cancer incidence and mortality rates represent a modification of the annual time series of July 1 county population estimates by age, sex, race, and Hispanic origin produced by the Population Estimates Program of the U.S. Census Bureau with support from NCI through an interagency agreement.
Primary Survey Content
Patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and followup for vital statistics.
Age-adjusted 2000 U.S. standard million population. For population modification, visit http://www.seer.cancer.gov/popdata.
Age, sex, race, year of diagnosis, and geographic areas.
National, States with registries.
Agency home page: http://www.cancer.gov.
Data system home page: http://www.seer.cancer.gov.
Ries LAG, Harkins D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER Web site 2006.
Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 13 Regs Limited-Use, Nov 2006 Sub (1992-2004)—Linked to County Attributes—Total U.S., 1969-2004 Counties. Bethesda, MD: National Cancer Institute, released April 2007, based on the November 2006 submission.
Return to Data Sources
United States Renal Data System (USRDS)
U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in collaboration with the U.S. Department of Health and Human Services, Centers for Medicare & Medicaid (CMS).
Mode of Administration
Continuous mandated reporting from physicians who treat end stage renal disease (ESRD).
Survey Sample Design
The database consists of patient and facility records from the CMS ESRD Program Management and Medical Information System, the Annual Facility Survey, and data on transplant followup and Medicare Part A and B services derived from Medicare claims. These CMS-supplied data are supplemented by data from the Social Security Administration, the U.S. Department of Veterans Affairs facilities, the U.S. Census Bureau, local and national ESRD provider databases, and international ESRD registries. Patient-specific data are compiled from medical records, as well as data on medical providers and treatment facilities. Special studies use random samples of patient population medical records.
Primary Survey Content
Date of onset of ESRD, treatment modality (including dialysis and kidney transplantation), causes of death, patient survival, hospitalization, cost and cost effectiveness, and institutional providers of ESRD treatment. Questions in special surveys cover behavioral risk factors (for example, alcohol and tobacco use), preventive health measures, health status, limitation of activity, and health care access and utilization.
Medicare and non-Medicare ESRD patients.
Age, sex, income, education, race, ethnicity.
Continuously since 1988.
National, State, and county.
The USRDS provides data on the incidence, prevalence, mortality rates, and trends over time of ESRD by primary diagnosis, treatment modality, and sociodemographic variables.
Agency home page: http://www.niddk.nih.gov.
Data system home page: http://www.usrds.org.
United States Renal Data System. Researcher's Guide to the USRDS Database. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
U.S. Renal Data System. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
Visit http://www.usrds.org for updated Annual Data Reports.
Return to Data Sources